Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2025 Revenue

Go back to Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2025 Revenue
Labranche & Co (NASDAQ: LAB) Delayed: 0.64 -0.01 (1.54%)
Previous Close $0.65    52 Week High $4.47 
Open $0.66    52 Week Low $3.02 
Day High $0.67    P/E N/A 
Day Low $0.64    EPS $-1.56 
Volume 1,260,474